MYBPC3 and infection: To evaluate the molecular impact of phosphomimetic (D282) and wild-type (S282) Mybpc3 AAV-mediated gene transfer, engineered heart tissues (EHTs) were derived from cardiac cells isolated from neonatal Mybpc3-targeted KI mice and transduced with a multiplicity of infection (MOI) of 1,000 vg/cell.